Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 3
1948 7
1949 7
1950 13
1951 10
1952 9
1953 26
1954 19
1955 31
1956 30
1957 53
1958 41
1959 63
1960 75
1961 104
1962 166
1963 338
1964 564
1965 540
1966 433
1967 553
1968 628
1969 758
1970 795
1971 761
1972 711
1973 721
1974 738
1975 794
1976 822
1977 818
1978 879
1979 818
1980 912
1981 1029
1982 1095
1983 1267
1984 1437
1985 1578
1986 1591
1987 1854
1988 2005
1989 2331
1990 2520
1991 2592
1992 2740
1993 2984
1994 3096
1995 3148
1996 3329
1997 3351
1998 3478
1999 3820
2000 3933
2001 4096
2002 4564
2003 4713
2004 5158
2005 5717
2006 5983
2007 6294
2008 6902
2009 7338
2010 7854
2011 8522
2012 9208
2013 9659
2014 10350
2015 10889
2016 11304
2017 11768
2018 12481
2019 13104
2020 15190
2021 17237
2022 10726
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

240,460 results
Results by year
Filters applied: . Clear all
Page 1
Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses.
Fousert E, Toes R, Desai J. Fousert E, et al. Cells. 2020 Apr 8;9(4):915. doi: 10.3390/cells9040915. Cells. 2020. PMID: 32276504 Free PMC article. Review.
Most likely, NETs contribute to breaking self-tolerance in autoimmune diseases in several ways. During this review, we discuss the current knowledge on how NETs could drive autoimmune responses. ...Therefore, NETs may be central regulators of inflammation and aut …
Most likely, NETs contribute to breaking self-tolerance in autoimmune diseases in several ways. During this review, we discuss the cu …
The autoimmune tautology.
Anaya JM. Anaya JM. Arthritis Res Ther. 2010;12(6):147. doi: 10.1186/ar3175. Epub 2010 Nov 9. Arthritis Res Ther. 2010. PMID: 21092150 Free PMC article. Review.
Although autoimmune diseases exhibit contrasting epidemiological features, pathology, and clinical manifestations, three lines of evidence demonstrate that these diseases share similar immunogenetic mechanisms (that is, autoimmune tautology). First, clinical evidenc …
Although autoimmune diseases exhibit contrasting epidemiological features, pathology, and clinical manifestations, three lines of evi …
The autoimmune tautology. A summary of evidence.
Anaya JM. Anaya JM. Joint Bone Spine. 2017 May;84(3):251-253. doi: 10.1016/j.jbspin.2016.11.012. Epub 2016 Dec 23. Joint Bone Spine. 2017. PMID: 28017820 Review. No abstract available.
[Primary immunodeficiency and autoimmune diseases].
Műzes G, Sipos F. Műzes G, et al. Orv Hetil. 2018 Jun;159(23):908-918. doi: 10.1556/650.2018.31064. Orv Hetil. 2018. PMID: 29860882 Review. Hungarian.
Patients with primary immunodeficiency are more prone to develop not only recurrent infections, but non-infectious complications, like inflammatory or granulomatous conditions, lymphoproliferative and solid malignancies, autoinflammatory disorders, and a broad spectrum of auto …
Patients with primary immunodeficiency are more prone to develop not only recurrent infections, but non-infectious complications, like infla …
Autoimmunity and immunological tolerance in autoimmune bullous diseases.
Takahashi H, Iriki H, Mukai M, Kamata A, Nomura H, Yamagami J, Amagai M. Takahashi H, et al. Int Immunol. 2019 Jul 13;31(7):431-437. doi: 10.1093/intimm/dxz030. Int Immunol. 2019. PMID: 30887049 Review.
Although autoantigens are ill-defined in most autoimmune diseases, this is not the case in the skin. Autoimmune bullous diseases have been extensively studied with detailed characterization of autoantigens, the epitopes that are targeted, and the mechanisms of actio …
Although autoantigens are ill-defined in most autoimmune diseases, this is not the case in the skin. Autoimmune bullous diseas …
Therapeutic tolerance in autoimmune disease.
Rayner F, Isaacs JD. Rayner F, et al. Semin Arthritis Rheum. 2018 Dec;48(3):558-562. doi: 10.1016/j.semarthrit.2018.09.008. Epub 2018 Sep 28. Semin Arthritis Rheum. 2018. PMID: 30348449 Review.
Therapeutic tolerance induction, whereby immune tolerance is used to treat or prevent transplant rejection, and as a treatment for autoimmunity, followed in the 1980s. Clinical translation has been slow but the pace of change is accelerating. ...Furthermore, technology has …
Therapeutic tolerance induction, whereby immune tolerance is used to treat or prevent transplant rejection, and as a treatment for autoim …
Autoimmune Biomarkers, Antibodies, and Immunologic Evaluation of the Patient with Fibrotic Lung Disease.
Tzouvelekis A, Karampitsakos T, Bouros E, Tzilas V, Liossis SN, Bouros D. Tzouvelekis A, et al. Clin Chest Med. 2019 Sep;40(3):679-691. doi: 10.1016/j.ccm.2019.06.002. Clin Chest Med. 2019. PMID: 31376900 Review.
This review summarizes the current state of knowledge on experimental and clinical biomarkers of autoimmunity and aims to highlight important aspects of the immunologic evaluation of a patient with fibrotic lung disease....
This review summarizes the current state of knowledge on experimental and clinical biomarkers of autoimmunity and aims to highlight i …
240,460 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "autoimmune"